Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal Hepatitis B Vaccination With Imiquimod in IBD Patients
NCT04083157Phase 3Completed
- Sponsor
- The University of Hong Kong
- Start
- Aug 2019
- Primary completion
- Dec 2020
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of imiquimod, Hepatitis B vaccine in hepatitis B (HBV), sponsored by The University of Hong Kong. Started Aug 2019; status: completed.
02
Drugs
imiquimodHepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT04083157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04083157.